In anticancer effect, Compound Mylabris Capsule has the effects of inhibiting the growth and proliferation of cancer cells, promoting the differentiation and maturation of cancer cells, promoting the apoptosis of cancer cells, and also inhibiting the spread and metastasis of cancer cells. It can inhibit the development of cancer, shrink tumor bodies and relieve symptoms. Compound Mylabris Capsule contains medicinal materials such as Scutellaria barbata, which has good anticancer effect and is helpful for cancer inhibition.
In terms of analgesic effect, Compound Mylabris Capsule also has a good improvement effect on pain caused by invasion and destruction of cancer cells and pain caused by tumor necrosis. Moreover, Compound Mylabris Capsule contains Rhizoma Sparganii and other medicinal materials, which has a good effect of promoting blood circulation and removing blood stasis, and has a good effect on the treatment and improvement of pain symptoms.
The pure medicinal preparation of compound mylabris capsule has the efficacy of strengthening the body resistance and consolidating the constitution, and has a good effect on improving immune function and enhancing immune system inhibition and killing cancer cells. Compound mylabris capsule contains ginseng, astragalus, acanthopanax senticosus, Ligustrum lucidum and other medicinal materials, and has a very significant effect on strengthening the body resistance and tonifying deficiency, and has a good effect on improving immune function.
In the efficacy of improving symptoms, Compound Mylabris Capsule is often used in the treatment of advanced malignant tumors. In addition to its extensive effect of inhibiting cancer and effectively inhibiting the metastasis of advanced cancer, it can also improve the symptoms of patients, especially for patients with increased and aggravated advanced symptoms. Compound Mylabris Capsule has a good effect of improving common pain in the late stage, and can effectively reduce the consumption of cancer for the body and reduce the occurrence of systemic symptoms by inhibiting cancer and shrinking tumor body.